The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, December 07, 2020
The FDA approved Danyelza for use in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients 1 year ...
read more
Monday, December 07, 2020
Glycostem Therapeutics announced the opening of a phase I/IIa trial for its lead product oNKord for the treatment of AML patients.
read more
Monday, December 07, 2020
RedHill Biopharma has initiated its Phase 3 study to evaluate the safety and efficacy of RHB-204 as a potential first-line, stand-alone, oral ...
read more
Monday, December 07, 2020
Eiger announced the FDA has approved Zokinvy for the treatment of Hutchinson-Gilford Progeria Syndrome and processing-deficient Progeroid ...
read more
Friday, December 04, 2020
SIFI has achieved the full enrollment of 135 patients with Acanthamoeba keratitis in its pivotal Phase III clinical trial.
read more
Friday, December 04, 2020
The Icahn School of Medicine at Mount Sinai and Boehringer Ingelheim announced the first patient has enrolled in a new clinical study to investigate ...
read more
Friday, December 04, 2020
Eli Lilly and Incyte announced the FDA issued an EUA for the distribution and use of baricitinib in combination with remdesivir in hospitalized ...
read more
Thursday, December 03, 2020
Samsung Bioepis and Biogen announced the FDA has accepted for review the BLA for SB11, a proposed biosimilar referencing Lucentis.
read more
Thursday, December 03, 2020
Pionyr Immunotherapeutics announced the initiation of a Phase 1 clinical study investigating PY314 in patients with solid tumors.
read more
Thursday, December 03, 2020
NeuroSense Therapeutics continues to report promising trends in their NST002 Phase IIa study, conducted in Israel at Tel-Aviv Sourasky Medical Center.
read more
Thursday, December 03, 2020
RedHill Biopharma announced that the global Phase 2/3 study with opaganib in patients hospitalized with severe COVID-19 pneumonia has received a ...
read more
Wednesday, December 02, 2020
Pfizer and BioNTech announced the MHRA in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine against ...
read more
Wednesday, December 02, 2020
Cellectis announced the FDA has lifted the clinical hold on the Phase 1 MELANI-01 trial evaluating the UCARTCS1 product candidate for the treatment of...
read more
Wednesday, December 02, 2020
BioLineRx announced the Company's lead drug candidate, the CXCR4-inhibitor Motixafortide, will be evaluated in an investigator-initiated clinical ...
read more
Tuesday, December 01, 2020
Pfizer and BioNTech have submitted a formal Application for CMA to the EMA for their mRNA vaccine candidate, BNT162b2, against COVID-19.
read more